NYXH · NYXOAH S A
Nyxoah SA, a medical technology company, focuses on the development and commercialization of solutions to treat obstructive sleep apnea. Its lead solution is the Genio system, a hypoglossal neurostimulations therapy for obstructive sleep apnea. The company was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.
Market Cap
129.3M
52 Wk Range
$1.26 - $6.88
Previous Close
$1.27
Open
$1.34
Volume
264,064
Day Range
$1.34 - $1.47
Enterprise Value
86.74M
Cash
97.79M
Avg Qtr Burn
-16.57M
Insider Ownership
33.19%
Institutional Own.
29.90%
Qtr Updated
Jun 30th 2026
